Two Sigma Securities, LLC Biomarin Pharmaceutical Inc Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

A detailed history of Two Sigma Securities, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Two Sigma Securities, LLC holds 9,100 shares of BMRN stock, worth $603,057. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,100

Previous 28,829 68.43%

Holding current value

$603,057

Previous $2.37 Million 73.07%

% of portfolio

0.01%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $5.15 Million - $7 Million	74,598 Added 258.76%	103,427 $7.27 Million
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $658,184 - $815,501	-8,843 Reduced 23.47%	28,829 $2.37 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $1.46 Million - $1.72 Million	17,364 Added 85.5%	37,672 $3.29 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $956,713 - $1.24 Million	12,552 Added 161.84%	20,308 $1.96 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $337,812 - $375,180	-3,971 Reduced 33.86%	7,756 $686,000
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $1.02 Million - $1.18 Million	11,727 New	11,727 $1.02 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $629,238 - $764,540	8,803 New	8,803 $730,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $250,479 - $286,324	-3,350 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $1.2 Million - $1.35 Million	-15,950 Reduced 82.64%	3,350 $280,000
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $127,677 - $199,373	-1,605 Reduced 7.68%	19,300 $2.38 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $1.08 Million - $1.45 Million	16,751 Added 403.25%	20,905 $1.77 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $516,342 - $683,409	-6,443 Reduced 60.8%	4,154 $354,000
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $1.88 Million - $2.11 Million	-19,968 Reduced 65.33%	10,597 $1.03 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $1.11 Million - $1.45 Million	14,623 Added 91.73%	30,565 $2.88 Million
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $986,253 - $1.18 Million	12,698 Added 391.43%	15,942 $1.29 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $261,985 - $308,601	3,244	3,244 $289,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account

Two Sigma Securities, LLC Biomarin Pharmaceutical Inc Transaction History